Puma Biotechnology Inc.

NASDAQ: PBYI · Real-Time Price · USD
5.73
0.41 (7.71%)
At close: Aug 15, 2025, 3:59 PM
5.79
1.05%
After-hours: Aug 15, 2025, 07:19 PM EDT

Puma Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
52.44M 46.01M 59.08M 80.54M 47.08M 43.77M 72.18M 56.12M 54.57M 52.77M 65.7M 57.1M 59.52M 45.74M 55.4M 46.24M 53.38M 98.17M
Cost of Revenue
12.3M 10.56M 13.92M 29.1M 10.66M 10.73M 24.32M 13.28M 11.86M 13.22M 16.8M 12.49M 14.92M 10.84M 11.9M 10.28M 11.97M 29.56M
Gross Profit
40.13M 35.45M 45.16M 51.45M 36.42M 33.04M 47.85M 42.83M 42.71M 39.56M 48.9M 44.61M 44.6M 34.89M 43.5M 35.97M 41.41M 68.61M
Operating Income
6.64M 3.98M 13.37M 22.08M -2.18M -2.3M 14.8M 8.59M 4.89M 4.37M 10M 9.67M 12.06M -684K 6.8M -8.95M -16.63M 20.15M
Interest Income
956K 1.1M 1.23M 1.28M 1.24M 972K 719K 689K 660K 537K 519K 216K 65K 13K 13K 13K 121K 13K
Pretax Income
6.17M 3.27M 12.24M 20.61M -4.15M -4.59M 12.8M 6.01M 2.31M 1.55M -5.3M -293K 9.43M -3.37M 4.4M -44.63M -5.07M 16.57M
Net Income
5.86M 2.97M 19.3M 20.32M -4.53M -4.82M 12.27M 5.8M 2.13M 1.4M -5.6M -360K 9.37M -3.4M 4.22M -44.67M -5.11M 16.53M
Selling & General & Admin
18.05M 17.6M 17.02M 16.87M 24.97M 21.75M 20.18M 22.18M 24.46M 22.49M 25.1M 23.96M 20.58M 20.4M 22.5M 26.08M 39.41M 28.24M
Research & Development
15.45M 13.86M 15.17M 12.55M 13.63M 13.59M 12.87M 11.45M 13.36M 12.71M 13.8M 11.25M 11.97M 15.24M 14.2M 18.84M 18.64M 20.23M
Other Expenses
n/a n/a -398K -48K n/a n/a n/a 625K 86K -42K -200K 64K 62K 50K 100K 71K 60K 42K
Operating Expenses
33.5M 31.47M 31.79M 29.37M 38.6M 35.34M 33.06M 34.25M 37.82M 35.19M 38.9M 35.21M 32.54M 35.64M 36.7M 44.92M 58.05M 48.47M
Interest Expense
1.84M 2.18M 2.62M 3.1M 3.37M 3.36M 3.35M 3.34M 3.33M 3.31M 3.28M 2.95M 2.7M 2.66M 2.7M 3.12M 3.52M 3.45M
Selling & Marketing Expenses
n/a n/a n/a n/a -183K 110K 367K n/a n/a n/a 61K n/a n/a n/a 38K n/a n/a n/a
Cost & Expenses
45.8M 42.02M 45.71M 58.46M 49.26M 46.06M 57.38M 47.53M 49.68M 48.41M 55.7M 47.71M 47.46M 46.48M 48.6M 55.2M 70.02M 78.02M
Income Tax Expense
310K -293K -7.07M 291K 378K 220K 536K 213K 187K 147K 300K 67K 57K 37K 200K 37K 38K 38K
Shares Outstanding (Basic)
49.7M 49.6M 49.1M 49.01M 48.29M 48.19M 47.6M 47.52M 46.76M 46.64M 45.81M 45.57M 45.06M 42.21M 40.99M 40.81M 39.28M 40.26M
Shares Outstanding (Diluted)
50.14M 49.91M 49.41M 49.17M 48.29M 48.19M 48.04M 47.82M 47.2M 47.16M 45.81M 45.57M 45.36M 42.21M 41.04M 40.81M 40.48M 40.89M
EPS (Basic)
0.12 0.06 0.39 0.41 -0.09 -0.1 0.26 0.12 0.05 0.03 -0.12 -0.01 0.21 -0.08 0.10 -1.09 -0.13 0.41
EPS (Diluted)
0.12 0.06 0.39 0.41 -0.09 -0.1 0.26 0.12 0.04 0.03 -0.12 -0.01 0.21 -0.08 0.10 -1.09 -0.13 0.40
EBITDA
10.77M 8.24M 17.7M 26.59M 2.13M 1.66M 18.31M 11.46M 8.51M 7.74M 174K 4.88M 14.52M 1.5M 9.1M -39.07M 1.39M 43.1M
EBIT
8M 5.44M 14.86M 23.71M -779K -1.24M 15.42M 8.59M 4.89M 4.37M -2.03M 2.65M 12.13M -702K 7.15M -41.51M -1.55M 40.15M
Depreciation & Amortization
2.76M 2.8M 2.84M 2.88M 2.91M 2.9M 2.89M 2.88M 2.88M 2.88M 2.21M 2.23M 2.29M 2.2M 2.27M 2.44M 2.94M 2.95M